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High-cholesterol diet does not alter gut
microbiota composition in mice
Lidiya G. Dimova1, Nikola Zlatkov2, Henkjan J. Verkade1, Bernt Eric Uhlin2 and Uwe J. F. Tietge1*
Abstract
Introduction: Western diet containing both saturated fat and cholesterol impairs cardio-metabolic health partly by
modulating diversity and function of the microbiota. While diet containing only high fat has comparable effects, it
is unclear how diets only enriched in cholesterol impact the microbiota. Therefore, we aimed to characterize the
response of host and microbiota to a high cholesterol (HC) diet in mice susceptible to cardio-metabolic disease.
Methods: LDLR knockout mice received either 1.25% HC or no cholesterol containing control diet (NC) for
12 weeks before characterizing host cholesterol metabolism and intestinal microbiota composition (next
generation sequencing).
Results: HC diet substantially increased plasma (1.6-fold) and liver cholesterol levels (21-fold), biliary cholesterol
secretion (4.5-fold) and fecal neutral sterol excretion (68-fold, each p < 0.001) but not fecal bile acid excretion.
Interestingly, despite the profound changes in intestinal cholesterol homeostasis no differences in microbial
composition between control and HC-fed mice were detected. In both groups the main phyla were Bacteroidetes
(55%), Firmicutes (27%) and Verrucomicrobia (14%).
Conclusion: Our results demonstrate that in mice HC diet alone does not alter the microbiota composition despite
inducing substantial adaptive changes in whole body cholesterol homeostasis. The impact of Western diet on
intestinal microbiota thus appears to be mediated exclusively by its high fat content.
Keywords: Diet, Cholesterol, microbiota, Ldlr-knockout, Bile, Neutral sterols
Introduction
The intestinal microbiota can exert profound effects on
the metabolism of the host. Changes in gut community
structure and function have been implied in metabolic
syndrome-related conditions such as obesity [1, 2], type
2 diabetes [3] and atherosclerosis [4, 5]. Diet emerges as
an important factor influencing microbiota composition
since nutrient abundance can promote the growth of dif-
ferent bacterial groups by affecting bacterial metabolism
and adaptability [6]. The shift from a low-fat plant-
polysaccharide-rich diet towards a high-fat Western style
diet has been shown to strongly modify the gut micro-
biota within days of administration [7] by increasing the
representatives of Mollicutes, Erysipelotrichi and Bacilli
classes of Firmicutes along the intestinal axis [8]. These
changes conceivably contribute to metabolic disease,
since the predominance of Firmicutes over Bacteroidetes
has been associated with obesity and metabolic syn-
drome in both mice [9] and humans [10]. High fat diet
has effects similar to Western diet on the gut ecosystem
[11] resulting in an altered metabolomic signature of
dominant phylotypes as Bacteroidetes [8] although this
has not been unequivocally established and the diet
effect might depend on additional factors such as the
choice of model [12]. However, in addition to high fat,
Western diet also contains high levels of dietary choles-
terol, leading to an increase in LDL cholesterol, the main
risk factor for cardiovascular disease development. Mice
lacking the intestinal cholesterol transporter Npc1l1
were shown to develop alterations in their gut micro-
biota compared to wild type mice [13]. Whether such
changes are due to an increased cholesterol abundance
in the intestine has thus far not been determined. Here,
we aimed to evaluate the impact of an exclusive in-
crease in dietary cholesterol on whole body cholesterol
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homeostasis as well as on the gut microbiome in Ldl-
receptor knockout mice. These mice were chosen since
they represent a widely used model for several aspects
of cardio-metabolic disease such as atherosclerosis [14]
or non-alcoholic steatohepatitis [15], pathologies in
which changes in microbiota composition have been
mechanistically implicated [4, 5, 16, 17]. Our results
demonstrate that the composition of the intestinal
microbiota remained remarkably stable despite substan-
tial changes occurring in overall cholesterol metabolism
in response to the HC diet. These data furthermore
imply that the impact of Western diet on the micro-




Male B6.129S7-Ldlrtm1Her mice (Jackson Laboratories,
Bay Harbor, Maine, USA) were bred in our facility. To
avoid confounding effects of kinship, the selected
animals included in this experiment were littermates.
After weaning they were individually housed under
temperature controlled conditions with 12 h light/dark
cycles. Mice were maintained on semisynthetic AIN93G
diet (D10012G, Research Diets) until 12 weeks of age
when half of them were switched to a 1.25%-cholesterol
containing re-formulation of the same diet (D12110502,
Research Diets comparable to previous work [18]),
which was then continued for an additional 12 weeks.
Food and water were provided ad libitum. All animal
experiments were approved by the Animal Care and
Use Committee at the University of Groningen, The
Netherlands.
Assessment of host cholesterol metabolism
Blood was collected by heart puncture and placed on
ice. Plasma was collected after centrifugation at
3000 rpm for 10 min at 4 °C and was used for colori-
metric quantification of total plasma cholesterol using
a commercially available kit (Roche, Mannheim,
Germany). For the determination of hepatic choles-
terol and triglyceride content, 300 mg of frozen tissue
were used for lipid extraction with the Bligh and Dyer
method. Lipids were dissolved at 37 °C in 0.1%
Triton-X100 in H2O and quantified with commer-
cially available kits (Roche, Mannheim, Germany).
Bile was continuously collected for 30 min after bil-
iary duct cannulation [19]. Cholesterol in the bile
was measured by gas chromatography after lipid ex-
traction using the general procedure of Bligh and
Dyer as described [20]. Bile acids in the bile were
quantified using a fluorometric assay as published [20].
For the determination of fecal neutral sterols and bile
acids, 50 mg of feces were saponified, followed by
separation of neutral and acidic sterols by triple petrol-
eum ether extraction [21]. The organic phase contain-
ing the neutral sterols, was processed as for
determination of biliary cholesterol. Total bile acids
were extracted from the aqueous phase using a SepPak-
18 column, methylated and measured by gas chroma-
tography [20].
Microbial community analysis
DNA was extracted from cecum contents using the
MoBio PowerFecal DNA extraction kit. The microbial
16S rRNA gene was amplified with barcoded universal
341 F-785R primers and the sequencing of the corre-
sponding products was performed at 300 bp paired-end
read with Illumina MiSeq V3 (LGC Genomics, Berlin,
Germany) to a total of 1 million read pairs. Demulti-
plexing of all samples was done using Illumina’s
CASAVA data analysis software. Reads with lower than
100 bp were discarded. 16S pre-processing and oper-
ational taxonomic unit (OTU) picking from amplicons
was carried out with Mothur 1.33 using the 16S Silva
reference alignment. The OTU picking by clustering
was set at 97% identity level using the cluster split
method. De novo phylogenetic tree generation was per-
formed with the FastTree method. Singleton OTUs
were excluded from the analysis, as were OTUs with a
relative abundance lower than 0.01%. The taxonomical
assignment of the OTUs and the calculations for α and
β diversity were executed with the QIIME pipeline. We
used UniFrac to determine which of the microbial com-
munities represented in our mice were significantly
different, as well as the basis for a distance matrix to
cluster the samples using Unweighted Pair Group Method
with Arithmetic Mean (UPGMA ) and to perform prin-
cipal component analysis.
Gene expression
Gene expression analysis was performed using quanti-
tative real-time PCR. After sacrifice the small intestine
was dissected and washed with PBS in the presence of a
protease inhibitor cocktail (cOmplete, Roche, Almere,
Netherlands). The tissue was snap-frozen and stored at
−80 °C until analysis. RNA was isolated using Trizol
reagent following the manufacturer’s instructions (Life
Technologies, Thermo Fischer Scientific). RNA was
quantified with NanoDrop 2000 (Life Technologies,
Thermo Fischer Scientific) and a total of 1 μg was used
for cDNA synthesis with M-MLV reverse transcriptase
(Sigma). Real time PCR was performed on a StepOne
RealTime PCR instrument (Applied Biosystems). Target
gene expression levels were normalized to the expres-
sion of the acidic ribosomal phosphoprotein 36b4.
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Statistical analysis
The differences between physiological parameters in
the groups were compared with the Mann–Whitney U-
test. Analysis of similarities was used to examine clus-
tering of microbial communities using the unweighted
UniFrac distance matrices. QIIME v 1.8.0 and R v3.3.0
with the packages phyloseq 1.4.5, cluster 1.14.4 and
ggplot2 0.9.3.1 were used for statistics and graphics.
Analyses at phylum and genus level were performed by
aggregating all OTUs which had identical classification
at the given taxonomic level, and normalizing samples
by their total abundance. We omitted the unclassified
taxa and taxa with mean relative abundance lower than
0.01% since the sample size was relatively small and the
analysis focused on taxa that were expressed in most
samples in order to get biologically meaningful results.
The statistical significance threshold we used was an
alpha of 0.05.
Results and discussion
High dietary cholesterol intake substantially changes
overall cholesterol metabolism
The addition of 1.25% cholesterol to a low fat semisyn-
thetic diet for 12 weeks did not induce changes in body
weight compared to the control diet with no added chol-
esterol (NC) (Table 1). However, mice fed the high-
cholesterol (HC) diet developed elevated plasma choles-
terol levels compared to control mice maintained on the
NC diet (+39%, p < 0.01) (Table 1). In addition, the HC
group had an increased hepatic content of cholesteryl es-
ters (+96%, p < 0.01) as well as triglycerides (+63%, p <
0.01). These data indicate, consistent with previous
findings, that feeding a diet enriched in cholesterol re-
sults in cholesterol accumulation in plasma and tissues
of Ldlr-knockout mice [22]. The mRNA expression of
Npc1l1 in the proximal small intestine, the main trans-
porter involved in cholesterol absorption, was not sig-
nificantly different between both experimental groups
(Additional file 1: Figure S1).
Cholesterol can either be cleared directly from the
systemic circulation [23] or by prior conversion to bile
acids [24]. HC feeding resulted in a 4.5-fold (p < 0.001,
Table 1) increase in biliary cholesterol secretion and a
68-times higher fecal neutral sterol excretion (p < 0.001).
On the other hand, both biliary bile acid secretion and
fecal bile acid excretion remained comparable between
the groups. However, certain microbial taxa are involved
in bile acid metabolism and can thereby substantially
Table 1 Metabolic changes in Ldlr-knockout mice after 12 weeks high-cholesterol diet feeding
Control (n = 4–6) High-cholesterol (n = 5–8) Significance
Metabolic parameter
Body weight (g) 26.91 (24.38 to 28.04) 27.07 (24.87 to 30.06) n.s.
Total plasma cholesterol (mmol/L) 10.55 (8.585 to 11.26) 17.27 (13.64 to 22.93) p < 0.01
Hepatic cholesterol (mmol/g) 0.60 (0.25 to 5.59) 12.60 (7.67 to 14.27) p < 0.01
Hepatic triglycerides (mmol/g) 1.51 (0.45 to 2.88) 4.05 (3.34 to 4.17) p < 0.01
Cholesterol balance
(μmol/day/100 g BW)
Biliary bile acids 32.89 (25.23 to 51.87) 35.21 (22.15 to 61.75) n.s.
Fecal bile acid (total) excretion 4.64 (3.74 to 16.55) 15.22 (2.59 to 22.69) n.s.
Biliary cholesterol secretion 7.76 (2.44 to 9.31) 34.94 (14.58 to 55.13) p < 0.001
Fecal neutral sterols excretion 6.56 (3.97 to 9.47) 448.5 (384.6 to 558.7) p < 0.001
Dietary cholesterol 2.93 (2.359 to 2.949) 439.6 (394.4 to 522.8) p < 0.001
Primary and secondary bile acids in feces
(μmol/day/100 g BW)
Allo-cholic acid 0.16 (0.09 to 1.28) 0.70 (0.06 to 1.08) n.s.
Alpha-muricholic acid 0.86 (0.60 to 2.50) 3.06 (0.21 to 7.25) n.s.
Deoxycholic acid 0.97 (0.30 to 3.98) 2.92 (0.12 to 6.33) n.s.
Cholic acid 2.86 (0.53 to 5.17) 2.05 (0.06 to 5.98) n.s.
Chenodeoxycholic acid 0.29 (0.08 to 0.48) 0.36 (0.04 to 0.59) n.s.
Hyodeoxycholic acid 0.10 (0.03 to 0.19) 0.15 (0.05 to 0.40) n.s.
Ursodeoxycholic acid 0.10 (0.02 to 0.17) 0.16 (0.05 to 0.50) n.s.
Beta-muricholic acid 0.68 (0.17 to 1.69) 2.58 (0.05 to 10.07) n.s.
Omega-muricholic acid 1.18 (0.41 to 3.53) 1.74 (0.09 to 3.53) n.s.
Data are given as median and range. Statistical significance was tested with Mann–Whitney U-test or two-way ANOVA post-hoc Bonferoni test
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affect the composition of fecal bile acids [25]. Primary
bile acids synthesized from cholesterol in hepatocytes
reach the intestinal lumen via the bile. In the large intes-
tine unabsorbed bile acids are first deconjugated by the
bacterial enzyme bile salt hydrolase; next they are dehy-
droxylated by bacteria to form the secondary bile acids
[26]. Thus, changes in the fecal bile acid composition
can provide important cues for an altered microbiota
function. However, HC diet did not induce any appre-
ciable change in the distribution of fecal secondary bile
acids when compared to the NC group (Table 1). The
results also indicate that the HC diet did not induce
adaptations in microbiota metabolism with respect to
bile acid conversion. However, these data still leave the
possibility that dietary HC critically affected overall
microbiota composition.
HC diet does not change cecal microbiota composition
We next applied a deep sequencing approach to obtain
an in depth characterization of the microbiota compos-
ition in the HC compared with the NC group. We first
compared the relative abundance of each bacterial
group and then calculated the ratio between Firmicutes
and Bacteroidetes and performed analyses of the 8 most
abundant classes. After setting the exclusion criteria for
low abundance to 0.01% a total of 683 OTUs were in-
cluded in the subsequent analysis.
Interestingly, there was no difference in either total or
relative abundance of the main microbial phyla in the
cecum despite the strong dietary intervention (Fig. 1a-c).
Cecal microbial composition of all mice was comprised
of Bacteroidetes (average 55% across all samples), and
Firmicutes (27%), followed by Verrucomicrobia (14%),
Proteobacteria (3.7%) and Actinobacteria (0.6%) (Fig. 1b).
The Shannon-Weiner index, a measure of the α-diversity
of the community, also did not differ between our test
groups on each taxa level (Fig. 1d, p = 0.9, Student t-test).
An increased ratio between Firmicutes and Bacteroidetes
has been previously observed in mice fed Western diet [2]
and similar data were obtained in response to a diet con-
taining only high fat without added cholesterol [27]. How-
ever, in our study feeding the high-cholesterol component
of Western diet alone did not affect the Firmicutes to
Bacteroidetes ratio (in either group 0.018 ± 0.004, n.s.),
and thus any proposed impact of cholesterol diet on this
ratio should be reconsidered. On the other hand, our
study does not allow to draw a conclusion about potential
effects of an altered Firmicutes to Bacteroidetes ratio on
host cholesterol metabolism. In order to test for similar-
ities between the microbiomes of NC and HC mice we
used a PCo analysis based on the unweighted UniFrac
values, which showed no clustering of the individual sam-
ples (Fig. 1e). The constructed unweighted UniFrac dis-
tance matrix, based on all 16S rRNA sequences obtained,
confirmed that all microbiomes were at a similar distance
to each other (Fig. 1f), reflecting their apparent similarity.
Although, there was an overall uniformity in the distri-
bution of bacterial groups across all samples, one notable
exception was the class of Tenericutes, and more specific-
ally the genus Anaeroplasma, which were only detected in
NC mice. Previously, the presence of Anaeroplasma, was
associated with diet-induced obesity [28]. Another notable
exception was the Firmicutes genus Turicibacter, which
was present in all HC mice but not detected in the NC
group. An increase in Turicibacter has previously been
correlated to the amount of cecal butyrate in rats fed a
barley-malt based diet with a high fat content [29]. How-
ever, it has also been found to decrease in response to
high-fat feeding in mice [30] suggesting that Turicibacter
might be responsive to components in the diet other than
fat. According to our results the increase in Turicibacter
could be related to cholesterol abundance of the diet. This
suggests a role of the bacterium for assimilation or
sequestration of cholesterol, as it has been previously
demonstrated for other colonic bacteria of the Firmicutes
group [31]. Clearly more research is needed to delineate
the pathophysiological importance of these bacteria with
low abundance and their potential products for their role
in cholesterol metabolism and their potential relevance
for the development of cardio-metabolic disease. However,
such studies are technically difficult, since the Turicibacter
genus consists of strict anaerobes with poor survival under
laboratory conditions [32].
Dietary cholesterol is structurally similar to plant sterols,
which however, are non-absorbable due to differences in
the side chain length [33]. A study in hamsters adding 5%
plant sterols to the diet revealed a decrease in several taxa
in fecal samples, among which Coriobacteriaceae and Ery-
sipelotrichaceae [34]. By displacing cholesterol from bile-
formed micelles in the intestine, plant sterols can increase
the total amount of unabsorbed cholesterol in the intes-
tine [35]. Thus plant sterol feeding could be expected to
result in increased exposure of intestinal bacteria to chol-
esterol, similar to our present work. However, differences
in the side chain between cholesterol and phytosterols as
well as parameters related to specific hamster gut micro-
bial populations may account for the different outcomes
of both studies. In humans, plant sterol supplementation
seems unrelated to microbiota composition and diversity
[36]. Together with our results these findings suggest that
plant sterols might have, at least with relevance to rodents,
an intrinsic biological activity on intestinal bacteria, which
is not shared by cholesterol.
The within-group variation in our study was minimal,
likely as a result of our decision to use littermates and
thus avoid confounding by kinship. Combined with the
depth of the sequencing analysis we therefore expect to
have generated sufficiently robust data, a view actually































































































































































































Fig. 1 The adaptive host response is not mediated by changes in cecal microbiota abundance. Relative abundance a in the individual mice b at
phylum levels and c the 8 most abundant genera taxa. d Shannon-Weiman indexes calculated per taxa. e Principal component analysis based on
unweighted UniFrac distances. f Heatmap of the coverage reads of OTUs, limited to 0.01% abundance level. Mice M1-M3 received no cholesterol
in the diet (NC), mice M4-M6 were fed high cholesterol diet (HC)
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shared by literature using a similar experimental design
[9, 37]. In addition, with our chosen approach we provide
limited estimates on changes that might occur in bacterial
metabolism. A more in-depth approach could include
meta-transcriptomics with subsequent evaluation of gen-
etic networks responding to an increased availability of
cholesterol. However, based on the absence of any major
detectable change with our current experimental design
we would not expect that even such an elaborate approach
would reveal substantial alterations in critical pathways of
bacterial metabolism. Another point not covered by our
present study is the potential impact that changes in
microbiota induced by factors other than dietary choles-
terol might have on cholesterol metabolism either locally
in the intestine or systemically. More research involving
e.g. conventionalized germ-free mouse models would be
required to address this point.
In summary, our results demonstrate that feeding a
high cholesterol diet alone does not result in major ap-
preciable alterations in the composition of the intestinal
microbiota. This indicates that the substantial adaptive
changes in whole body cholesterol homeostasis occur
independently from microbial adaptations. We also con-
clude that the impact of Western diet on the microbiota
is exclusively mediated by its high fat content.
Additional file
Additional file 1: Figure S1. Relative expression of Npc1l1 mRNA in
small intestine of mice after 12 weeks on control or 1.25% cholesterol
diet (HC). Data is mean ± SEM. Statistical significance was tested with
Mann-Whitney U-test. (PDF 185 kb)
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